CA2536548C - Methode pour ameliorer la performance reproductive de mammiferes en incluant des acides linoleiques conjugues dans leur regime alimentaire - Google Patents
Methode pour ameliorer la performance reproductive de mammiferes en incluant des acides linoleiques conjugues dans leur regime alimentaire Download PDFInfo
- Publication number
- CA2536548C CA2536548C CA2536548A CA2536548A CA2536548C CA 2536548 C CA2536548 C CA 2536548C CA 2536548 A CA2536548 A CA 2536548A CA 2536548 A CA2536548 A CA 2536548A CA 2536548 C CA2536548 C CA 2536548C
- Authority
- CA
- Canada
- Prior art keywords
- trans
- cis
- cla
- fed
- clas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940108924 conjugated linoleic acid Drugs 0.000 title claims abstract description 64
- 230000001850 reproductive effect Effects 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 41
- 241000124008 Mammalia Species 0.000 title claims abstract description 30
- 230000002708 enhancing effect Effects 0.000 title description 6
- 241000283690 Bos taurus Species 0.000 claims abstract description 81
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 235000013365 dairy product Nutrition 0.000 claims abstract description 24
- 230000032696 parturition Effects 0.000 claims abstract 2
- 230000035935 pregnancy Effects 0.000 claims description 14
- 241000282849 Ruminantia Species 0.000 claims description 12
- 230000016087 ovulation Effects 0.000 claims description 11
- 210000004767 rumen Anatomy 0.000 claims description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- 230000004083 survival effect Effects 0.000 claims description 8
- 241000030538 Thecla Species 0.000 claims description 7
- 238000012423 maintenance Methods 0.000 claims description 7
- 241000283707 Capra Species 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 5
- 235000015278 beef Nutrition 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 241000283073 Equus caballus Species 0.000 claims 1
- 241000009328 Perro Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 230000006872 improvement Effects 0.000 abstract description 10
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 78
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 52
- 238000011282 treatment Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 12
- 239000013589 supplement Substances 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 239000008267 milk Substances 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 230000035558 fertility Effects 0.000 description 7
- 230000006651 lactation Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000000186 progesterone Substances 0.000 description 5
- 229960003387 progesterone Drugs 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000012173 estrus Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000283086 Equidae Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 230000009027 insemination Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical class CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical class C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 210000003165 abomasum Anatomy 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000006286 nutrient intake Nutrition 0.000 description 2
- 235000021048 nutrient requirements Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- IOCYQQQCJYMWDT-UHFFFAOYSA-N (3-ethyl-2-methoxyquinolin-6-yl)-(4-methoxycyclohexyl)methanone Chemical compound C=1C=C2N=C(OC)C(CC)=CC2=CC=1C(=O)C1CCC(OC)CC1 IOCYQQQCJYMWDT-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001442654 Percnon planissimum Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NGCGMRBZPXEPOZ-HBBGHHHDSA-N acetic acid;(2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-[(2s)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)- Chemical compound CC(O)=O.C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 NGCGMRBZPXEPOZ-HBBGHHHDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000012382 advanced drug delivery Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000003043 biohydrogenation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940002533 cystorelin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940090213 lutalyse Drugs 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 208000022638 pyogenic arthritis-pyoderma gangrenosum-acne syndrome Diseases 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
Abstract
Cette invention offre des méthodes damélioration du rendement de reproduction de vaches en lactation quotidienne et autres mammifères. Dans le cas de vaches, la méthode comprend lalimentation des vaches, une composition qui comprend des acides linoléiques conjugués (CLA), cis-9, trans-11 et trans-10, cis-12. Quand ces CLA sont donnés à des vaches laitières au moment ou avant de mettre bas, et que leur administration se poursuit après la parturition, une amélioration dans le rendement de reproduction est observée.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2005/39360 | 2005-12-15 | ||
| ARP060100574A AR052208A1 (es) | 2006-02-17 | 2006-02-17 | Metodo para mejorar la funcion reproductiva de los mamiferos alimentandolos con acidos linoleicos conjugados |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2536548A1 CA2536548A1 (fr) | 2007-06-15 |
| CA2536548C true CA2536548C (fr) | 2014-10-21 |
Family
ID=37820485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2536548A Active CA2536548C (fr) | 2005-12-15 | 2006-02-14 | Methode pour ameliorer la performance reproductive de mammiferes en incluant des acides linoleiques conjugues dans leur regime alimentaire |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR052208A1 (fr) |
| AU (1) | AU2006200647C1 (fr) |
| BR (1) | BRPI0600495A (fr) |
| CA (1) | CA2536548C (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104082622A (zh) * | 2014-06-25 | 2014-10-08 | 江苏绿茵生物科技有限公司 | 一种怀孕母兔专用饲料配方 |
| CN112451512A (zh) * | 2020-11-26 | 2021-03-09 | 青海省人民医院 | 一种药物组合物及其治疗骨质疏松的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0100421A (pt) * | 2001-01-12 | 2002-09-10 | Fundacao De Amparo A Pesquisa | Produto para alimentação de mamìferos visando aumentar o teor e/ou produção de proteìna no leite, processo de obtenção de aumento de produção e/ou teor de proteìna no leite e processo de obtenção de leite que propicia maior rendimento e/ou qualidade dos produtos lácteos produzidos a partir deste leite |
| RU2180311C1 (ru) * | 2001-07-05 | 2002-03-10 | Мешалкин Георгий Алексеевич | Защитная пробка |
-
2006
- 2006-02-14 CA CA2536548A patent/CA2536548C/fr active Active
- 2006-02-16 AU AU2006200647A patent/AU2006200647C1/en active Active
- 2006-02-16 BR BRPI0600495-4A patent/BRPI0600495A/pt not_active Application Discontinuation
- 2006-02-17 AR ARP060100574A patent/AR052208A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2536548A1 (fr) | 2007-06-15 |
| AU2006200647C1 (en) | 2013-04-04 |
| AU2006200647B2 (en) | 2012-12-06 |
| AU2006200647A1 (en) | 2007-07-05 |
| BRPI0600495A (pt) | 2007-10-09 |
| AR052208A1 (es) | 2007-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7935730B2 (en) | Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids | |
| Douglas et al. | Prepartum nutrition alters fatty acid composition in plasma, adipose tissue, and liver lipids of periparturient dairy cows | |
| Fuentes et al. | Effect of extruded linseed on productive and reproductive performance of lactating dairy cows | |
| Nazir et al. | Improvement of conception rate in postpartum flaxseed supplemented buffalo with Ovsynch+ CIDR protocol | |
| Muegge et al. | Supplementation of organic and inorganic selenium to late gestation and early lactation beef cows effect on cow and preweaning calf performance | |
| Shee et al. | Feeding dried distillers grains with solubles to lactating beef cows: impact of excess protein and fat on cow performance, milk production and pre-weaning progeny growth | |
| Long et al. | Reproductive performance and serum fatty acid profiles of underdeveloped beef heifers supplemented with saturated or unsaturated rumen bypass fat compared to an isocaloric control | |
| CA2536548C (fr) | Methode pour ameliorer la performance reproductive de mammiferes en incluant des acides linoleiques conjugues dans leur regime alimentaire | |
| Sah et al. | A clinical study of anestrus buffaloes in Southern Nepal | |
| Shike et al. | Influences of corn co-products in limit-fed rations on cow performance, lactation, nutrient output, and subsequent reproduction | |
| Espinoza et al. | Milk composition, postpartum reproductive activity and growth of lambs in Pelibuey ewes fed calcium soaps of long chain fatty acids | |
| RU2404579C2 (ru) | Способ улучшения репродуктивной функции у самок жвачных млекопитающих | |
| Mohammadi et al. | Effects of prepartum monensin feeding on energy metabolism and reproductive performance of postpartum high-producing Holstein dairy cows | |
| Khalifa et al. | Supplementing non-conventional energy sources to rations for improving production and reproduction performances of dairy Zaraibi nanny goats. | |
| Moriel et al. | Plasma fatty acids and reproductive performance of lactating beef cows fed rumen-protected fat | |
| Staples et al. | Feeding fatty acids for fertility | |
| Hifzulrahman et al. | Effects of feeding calcium salts of palm fatty acids on lactation and reproduction performance in Nili Ravi buffaloes. | |
| Ishmais et al. | Body weight change, milk production and reproductive parameters in suckled vs. non-suckled Awassi ewes | |
| JP2008508894A (ja) | 家畜用の補助飼料とその使用方法 | |
| Mahboub et al. | The effect of protected fat and selenium-vitamin E supplementation during late pregnancy on performance of local Egyptian goat breeds and survival of their kids. 11th Sci | |
| Snyder | Evaluating Sources of Omega-3 Fatty Acids for Their Benefits on Late Gestation Mares and Neonatal Foals | |
| Alizadeh et al. | Effects of calcium salts of fatty acids (Megalac) on reproductive performance and blood parameters of Kalkohi ewes. | |
| Koluman et al. | Cow, Sheep and Goat Colostrum Content Comparisons | |
| Schroeder | Effects of ꙍ6: ꙍ3 Fatty Acid Supplementation During Prepartum Period to Dairy Cows on Immunity and Performance | |
| Averós et al. | Pre-Partum Supplementation with Polyunsaturated Fatty Acids on Colostrum Characteristics and Lamb Immunity and Behavior after a Mild Post-Weaning Aversive Handling Period. Animals 2022, 12, 1780 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |